CNSX:BOSS

Global X Founder-Run Companies ETF Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume189,964 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Global X Founder-Run Companies ETF (CNSX:BOSS) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying BOSS stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Global X Founder-Run Companies ETF, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

Global X Founder-Run Companies ETF vs. (THCX.V) Stock

Global X Founder-Run Companies ETF (CNSX:BOSS) and (THCX.V) (CVE:THCX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation.

Earnings and Valuation

This table compares Global X Founder-Run Companies ETF and (THCX.V)'s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A
(THCX.V)	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of current recommendations for Global X Founder-Run Companies ETF and (THCX.V), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global X Founder-Run Companies ETF	0	0	0	0	N/A
(THCX.V)	0	0	0	0	N/A

Profitability

This table compares Global X Founder-Run Companies ETF and (THCX.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global X Founder-Run Companies ETF	N/A	N/A	N/A
(THCX.V)	N/A	N/A	N/A

Global X Founder-Run Companies ETF vs. 31444 Stock

31444 (CNSX:GLH) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.

Earnings & Valuation

This table compares 31444 and Global X Founder-Run Companies ETF's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
31444	N/A	N/A	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings for 31444 and Global X Founder-Run Companies ETF, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
31444	0	0	0	0	N/A
Global X Founder-Run Companies ETF	0	0	0	0	N/A

Profitability

This table compares 31444 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
31444	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A

Global X Founder-Run Companies ETF vs. 438280 Stock

438280 (CNSX:ACG) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.

Earnings & Valuation

This table compares 438280 and Global X Founder-Run Companies ETF's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
438280	N/A	N/A	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings for 438280 and Global X Founder-Run Companies ETF, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
438280	0	0	0	0	N/A
Global X Founder-Run Companies ETF	0	0	0	0	N/A

Profitability

This table compares 438280 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
438280	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A

Global X Founder-Run Companies ETF vs. 815446 Stock

815446 (CNSX:HC) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation.

Earnings & Valuation

This table compares 815446 and Global X Founder-Run Companies ETF's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
815446	N/A	N/A	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares 815446 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
815446	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings for 815446 and Global X Founder-Run Companies ETF, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
815446	0	0	0	0	N/A
Global X Founder-Run Companies ETF	0	0	0	0	N/A

Global X Founder-Run Companies ETF vs. Bio-Rad Laboratories Stock

Bio-Rad Laboratories (CNSX:BIO) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Valuation & Earnings

This table compares Bio-Rad Laboratories and Global X Founder-Run Companies ETF's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Bio-Rad Laboratories and Global X Founder-Run Companies ETF, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	0	0	0	0	N/A
Global X Founder-Run Companies ETF	0	0	0	0	N/A

Profitability

This table compares Bio-Rad Laboratories and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	N/A	N/A	N/A
Global X Founder-Run Companies ETF	N/A	N/A	N/A

Global X Founder-Run Companies ETF vs. Blueberries Medical Stock

Global X Founder-Run Companies ETF (CNSX:BOSS) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.

Valuation & Earnings

This table compares Global X Founder-Run Companies ETF and Blueberries Medical's gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global X Founder-Run Companies ETF	N/A	N/A	N/A	N/A	N/A
Blueberries Medical	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations for Global X Founder-Run Companies ETF and Blueberries Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global X Founder-Run Companies ETF	0	0	0	0	N/A
Blueberries Medical	0	0	0	0	N/A

Profitability

This table compares Global X Founder-Run Companies ETF and Blueberries Medical's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global X Founder-Run Companies ETF	N/A	N/A	N/A
Blueberries Medical	N/A	N/A	N/A